Menu

Blog

Apr 15, 2023

Myogenic tissue nanotransfection improves muscle torque recovery following volumetric muscle loss

Posted by in category: futurism

Year 2022 face_with_colon_three


This work rests on our non-viral tissue nanotransfection (TNT) platform to deliver MyoD (TNTMyoD) to injured tissue in vivo. TNTMyoD was performed on skin and successfully induced expression of myogenic factors. TNTMyoD was then used as a therapy 7 days following volumetric muscle loss (VML) of rat tibialis anterior and rescued muscle function. TNTMyoD is promising as VML intervention.

Comments are closed.